| 2003 |
OMA1 (Oma1) is a novel conserved metallopeptidase embedded in the mitochondrial inner membrane that degrades misfolded membrane proteins (e.g., a misfolded derivative of Oxa1) in an ATP-independent manner, with its proteolytic center exposed to the matrix side; it was identified as a component of the mitochondrial inner membrane quality control system overlapping with the m-AAA protease. |
Biochemical fractionation, in vitro protease assays, cleavage-site mapping of Oxa1 substrate in yeast |
The Journal of biological chemistry |
High |
12963738
|
| 2009 |
OMA1 mediates stress-induced (loss of membrane potential or ATP) proteolytic cleavage of OPA1 at the S1 site in mammalian cells, converting long OPA1 isoforms to short isoforms and inhibiting mitochondrial fusion; siRNA knockdown of OMA1 inhibits this inducible cleavage, retains fusion competence, and slows apoptosis. OMA1 itself is normally processed from 60 kDa to 40 kDa, and loss of membrane potential causes 60-kDa OMA1 to accumulate, suggesting OMA1 activity is attenuated by proteolytic degradation. |
siRNA knockdown, Western blot for OPA1 isoforms, live-cell imaging of mitochondrial morphology, CCCP/oligomycin treatment |
The Journal of cell biology |
High |
20038677 20038678
|
| 2009 |
Two classes of metallopeptidases regulate OPA1 cleavage in the mitochondrial inner membrane: isoenzymes of the m-AAA protease (paraplegin, AFG3L1, AFG3L2) for constitutive processing, and the ATP-independent OMA1 for stress-induced processing. Loss of AFG3L2 or mitochondrial DNA depletion induces OPA1 processing specifically by OMA1, linking distinct peptidases to constitutive versus induced OPA1 cleavage. |
Knockout/knockdown of AFG3L1/2, dominant-negative AFG3L2 expression, siRNA, Western blot for OPA1 isoforms, electron microscopy |
The Journal of cell biology |
High |
20038678
|
| 2012 |
In vivo, OMA1 deficiency in mice prevents stress-induced OPA1 proteolytic inactivation, causing a persistent mitochondrial fusion/fission imbalance that results in obesity, hepatic steatosis, decreased energy expenditure, and impaired thermogenesis, establishing OMA1 as essential for metabolic homeostasis via OPA1 regulation. |
Oma1 knockout mice, metabolic phenotyping, Western blot for OPA1 isoforms, transcriptional profiling, high-fat diet challenge |
The EMBO journal |
High |
22433842
|
| 2014 |
YME1L and OMA1 cleave OPA1 at two distinct sites (S2 and S1, respectively) to balance mitochondrial fusion and fission. Long OPA1 forms are sufficient for mitochondrial fusion; short OPA1 forms (generated by OMA1) promote fission and partially colocalize with ER-mitochondria contact sites and the mitochondrial fission machinery. Deletion of OMA1 rescued mitochondrial tubulation, cristae morphogenesis, and apoptotic resistance in YME1L-null cells. |
YME1L/OMA1 double knockout cells, mitochondrial morphology imaging, electron microscopy, apoptosis assays, expression of GTPase-inactive short OPA1 |
The Journal of cell biology |
High |
24616225
|
| 2014 |
OMA1 is constitutively active but undergoes strongly enhanced proteolytic activity in response to various stress insults (mitochondrial depolarization, heat, oxidative stress). An N-terminal stress-sensor domain (present only in higher eukaryotes) modulates OMA1 activation. OMA1 activation is coupled to its own autocatalytic degradation initiating from both termini, ensuring reversibility of the stress response and allowing OPA1-mediated fusion to resume upon stress alleviation. |
OMA1 truncation/domain mutant analysis, in-cell stress assays, Western blot for OMA1 and OPA1 isoforms, pulse-chase degradation experiments |
The EMBO journal |
High |
24550258
|
| 2014 |
Oligomerized Bax and Bak activate OMA1 in a Bax/Bak-dependent fashion during apoptosis; activated OMA1 then cleaves OPA1, which is critical for mitochondrial cristae remodeling. Knockdown or knockout of OMA1 attenuates cytochrome c release, placing OMA1 downstream of Bax/Bak oligomerization in the apoptotic pathway. |
Inducible Bim/tBid expression cell lines, OMA1 siRNA/KO, cytochrome c release assays, Western blot for OPA1 isoforms |
Proceedings of the National Academy of Sciences of the United States of America |
High |
25275009
|
| 2014 |
OMA1-mediated OPA1 proteolysis plays a critical role in mitochondrial fragmentation and apoptosis during ischemic acute kidney injury. OMA1 knockdown in renal tubular cells suppressed OPA1 cleavage, mitochondrial fragmentation, cytochrome c release, and apoptosis; OMA1-deficient mice were protected from ischemic AKI with better renal function and less tubular damage. |
OMA1 siRNA knockdown in proximal tubular cells, OMA1 knockout mice, ischemia-reperfusion model, Western blot, mitochondrial morphology imaging, renal function assays |
American journal of physiology. Renal physiology |
High |
24671334
|
| 2014 |
Stress-triggered activation of OMA1 (Oma1) involves conformational changes within its homo-oligomeric complex associated with C-terminal residues. Substitutions in the conserved C-terminal region impair formation of the labile proteolytically active complex in response to stress stimuli. OMA1 genetically interacts with other inner membrane-bound quality control proteases in yeast. |
Oma1 C-terminal mutagenesis in yeast, native gel electrophoresis of Oma1 complexes, protease activity assays, genetic interaction screens |
The Journal of biological chemistry |
Medium |
24648523
|
| 2019 |
PINK1 import into depolarized mitochondria can be cleaved and degraded by the OMA1 protease when PINK1 fails to arrest at the outer mitochondrial membrane. Tom7 and OMA1 exert opposing ('tug-of-war') effects on PINK1 accumulation: deletion of Tom7 allows PINK1 import into depolarized mitochondria where it is cleaved by OMA1, while OMA1 suppression rescues defective import arrest seen with certain Parkinson's disease PINK1 mutations. |
Tom7/OMA1 siRNA and KO, PINK1 import assays, PINK1 mutant rescue experiments, Western blot for PINK1 cleavage |
Molecular cell |
High |
30733118
|
| 2019 |
Prohibitin (PHB1/PHB2) promotes OMA1 turnover in neurons, effectively decreasing the pool of active OMA1. OMA1 binds to cardiolipin (CL), a major mitochondrial phospholipid, and CL binding promotes OMA1 turnover; deletion of the CL-binding domain of OMA1 decreases its turnover rate. This PHB-mediated CL stabilization regulates OMA1 activity and downstream cytochrome c release. |
PHB2 KO neurons, OMA1 domain deletion mutants, cardiolipin-binding assays, OMA1 turnover pulse-chase experiments, cytochrome c release assays, caspase activation |
Cell death and differentiation |
High |
31819158
|
| 2019 |
Oma1 is a redox-dependent protein existing in a semi-oxidized state. Two IMS-exposed conserved cysteine residues (Cys272 and Cys332) form a disulfide bond that plays a structural role influencing conformational stability and proteolytic activity of the Oma1 oligomeric complex. Reduction/oxidation of these residues dynamically tunes Oma1 activity and stability in both yeast and mammalian mitochondria. |
Cysteine mutagenesis, redox state analysis by alkylation/gel-shift, in vitro substrate engagement assays, genetic validation in yeast |
Antioxidants & redox signaling |
High |
31044600
|
| 2020 |
Mitochondrial stress activates OMA1-dependent cleavage of DELE1, releasing a short DELE1 fragment that accumulates in the cytosol where it interacts with and activates the eIF2α kinase HRI, thereby phosphorylating eIF2α and inducing ATF4 translation—constituting the OMA1-DELE1-HRI pathway that relays mitochondrial stress to the integrated stress response. |
Genome-wide CRISPRi screen, OMA1/DELE1/HRI knockdown, DELE1 cleavage assays, co-immunoprecipitation of DELE1 with HRI, eIF2α phosphorylation measurement, ATF4 reporter assays |
Nature |
High |
32132707
|
| 2020 |
Loss of both CHCHD2 and CHCHD10 activates OMA1, which cleaves L-OPA1, causing disrupted mitochondrial cristae. OMA1 activation similarly occurs in affected tissues of mutant CHCHD10 knock-in mice. Partial functional redundancy between CHCHD2 and CHCHD10 was demonstrated using OMA1 activation as a functional assay. |
CHCHD2/CHCHD10 double-knockout mice, CHCHD10 knock-in mice, OMA1 activity/OPA1 cleavage assays, electron microscopy, cardiomyopathy phenotyping |
Human molecular genetics |
High |
32338760
|
| 2021 |
OMA1 associates dynamically with the MICOS complex via the subunit MIC60, independently of OPA1. This OMA1-MICOS association is required for stability of MICOS and intermembrane contacts, as well as for optimal bioenergetic output and apoptosis. Loss of OMA1 disrupts these activities, which can be alleviated by a MICOS-emulating intermembrane bridge. |
Co-immunoprecipitation of OMA1 with MICOS subunits, OMA1 KO cells, bioenergetics assays, synthetic rescue with intermembrane bridge construct |
iScience |
Medium |
33644718
|
| 2022 |
In CHCHD10 mitochondrial myopathy, OMA1 mediates a coordinated local and global stress response: locally, OMA1 drives mitochondrial fragmentation; globally, OMA1 cleaves DELE1 to activate the integrated stress response. OMA1-dependent survival was essential for neonatal survival in CHCHD10-KI mice conditionally under inner mitochondrial membrane stress. |
CHCHD10 knock-in mouse model, OMA1 KO crosses, DELE1 cleavage assays, mitochondrial morphology, survival analysis, isoform profiling |
The Journal of clinical investigation |
High |
35700042
|
| 2023 |
TIM23 forms a physical complex with PINK1 and facilitates PINK1 accumulation by protecting it from OMA1-mediated degradation upon mitochondrial depolarization. Inactivation of OMA1 enhances PINK1 accumulation and compensates for TIM23 downregulation, and rescues defects in pathogenic PINK1 mutants that fail to interact with TIM23. |
Mass spectrometry of PINK1 co-immunoprecipitates, TIM23 knockdown, OMA1 KO, PINK1 autophosphorylation assays, PINK1 mutant rescue experiments |
Cell reports |
High |
37160114
|
| 2023 |
Mitochondrial cysteine 403 of OMA1 constitutes a redox-sensing site in mammalian cells. Prime editing of OMA1 C403A in mouse sarcoma cells impaired mitochondrial stress responses including ATP production, mitochondrial fission, and apoptosis, and enhanced mitochondrial DNA release, demonstrating a functional redox switch. |
Prime editing (C403A mutation), mitochondrial stress assays, mitochondrial DNA release measurement, apoptosis assays, immunocompetent tumor models |
Life science alliance |
Medium |
37024121
|
| 2023 |
OMA1 protects against DNA damage-induced apoptosis through metabolic control of glycolysis rather than through OPA1 or DELE1 processing. OMA1-deficient cells show reduced glycolysis and accumulate OXPHOS proteins upon DNA damage; OXPHOS inhibition restores glycolysis and resistance to DNA damage. |
CRISPR screen (metabolism-focused), OMA1 KO cells, metabolic flux assays, OXPHOS inhibitor rescue, apoptosis assays |
Cell reports |
Medium |
37002921
|
| 2024 |
OMA1 cleaves arrested import intermediates in the mitochondrial translocase upon mitochondrial membrane depolarization in human cells, releasing the stalled protein fragment from the translocase channel. The released fragment is subsequently cleared in the cytosol by VCP/p97 and the proteasome. |
Translocase clogging cell model, OMA1 KO/KD, Western blot for cleavage fragments, VCP/proteasome inhibitors |
The Journal of cell biology |
High |
38530280
|
| 2024 |
OMA1-dependent OPA1 processing is sensitive to both mitochondrial membrane potential depolarization and oxidative stress in neuronal cells; oxidative stress is necessary for depolarization-induced OMA1-mediated proteolysis. OMA1 KO cells show exacerbated acute mitochondrial fragmentation but better restorative fusion after stress due to preserved L-OPA1. |
OMA1 KO HT22 cells, mitochondrial morphology imaging, ROS measurement, oxygen-glucose deprivation/reoxygenation model, OPA1 isoform Western blot |
FASEB journal |
Medium |
39312414
|
| 2025 |
Parkin (ubiquitin E3 ligase) and OMA1 (metalloprotease) constitute a dual regulatory system that safeguards mitochondrial structure and genome via mitochondrial fusion mediated by MFN1 (outer membrane) and OPA1 (inner membrane). Individual loss of Parkin or OMA1 does not affect mitochondrial integrity, but combined loss causes small body size, low locomotor activity, premature death, mitochondrial abnormalities, and innate immune responses. |
18 single/double/triple whole-body and tissue-specific KO and mutant mice, mitochondrial morphology analysis, untargeted metabolomics, RNA sequencing |
Nature |
High |
39972141
|
| 2026 |
OMA1 cleaves AIFM1 (AIF/apoptosis-inducing factor) in the intermembrane space under mitochondrial stress conditions, with slower kinetics than OPA1 cleavage. This OMA1-mediated AIFM1 dislocation from the inner membrane reduces AIFM1 interactions with OXPHOS subunits, decreasing respiratory activity and impairing cell growth. Under steady-state conditions, AIFM1 broadly mediates import of respiratory complex I subunits via the TIM23 complex. |
In vitro and in vivo multiproteomic approaches, biochemical cleavage assays, OMA1 KO, co-immunoprecipitation of AIFM1 with OXPHOS subunits, respiratory activity measurement, mitochondrial protein import assays |
The EMBO journal |
High |
41876740
|
| 2026 |
OMA1 cleaves the mitochondrial chaperone DNAJC15, promoting its degradation by the m-AAA protease AFG3L2 under cellular stress. Loss of DNAJC15 impairs mitochondrial protein import and restricts OXPHOS biogenesis under conditions of mitochondrial dysfunction; non-imported preproteins accumulate at the ER, inducing an unfolded protein response. |
OMA1 KO, DNAJC15 cleavage assays, m-AAA protease interaction experiments, mitochondrial protein import assays, OXPHOS biogenesis quantification, ER stress reporters |
Nature structural & molecular biology |
High |
41760807
|
| 2018 |
Leptin-mediated protection of mitochondrial integrity in mesenchymal stem cells requires GSK3 phosphorylation as a prerequisite for ubiquitination-dependent proteasomal degradation of OMA1, thereby attenuating OMA1-mediated OPA1 cleavage. The proteasome inhibitor MG132 prevented leptin-induced OMA1 degradation, and GSK3 inhibitor (SB216763) also reduced OMA1 levels. |
Leptin treatment of hMSCs, MG132/GSK3 inhibitor treatment, OMA1/OPA1 Western blot, OPA1 siRNA rescue, mitochondrial morphology imaging |
Cell death & disease |
Medium |
29748581
|
| 2019 |
OMA1 links mitochondrial protein quality control to TOR signaling in yeast: inactivation of Oma1 leads to enhanced ROS production during logarithmic growth and reduced stress signaling via the TORC1-Rim15-Msn2/Msn4 axis. Pharmacological or genetic ROS prevention in Oma1-deficient cells restores defective TOR signaling. |
Oma1 KO yeast, ROS measurement, genetic epistasis with TORC1 pathway components, pharmacological ROS inhibition |
Molecular and cellular biology |
Medium |
27325672
|
| 2024 |
OMA1 competitively binds to HSPA9 in glioblastoma cells, inducing mitophagy and promoting cGAS-STING activation through increased mitochondrial DNA release, which upregulates PD-L1 transcription and contributes to immune evasion. |
Co-immunoprecipitation, mass spectrometry, immunofluorescence, OMA1 KD, cGAS-STING pathway assays, PD-L1 measurement |
Journal for immunotherapy of cancer |
Medium |
38604814
|